TWI351277B - Compositions containing reduced coenzyme q10 and c - Google Patents
Compositions containing reduced coenzyme q10 and c Download PDFInfo
- Publication number
- TWI351277B TWI351277B TW094110887A TW94110887A TWI351277B TW I351277 B TWI351277 B TW I351277B TW 094110887 A TW094110887 A TW 094110887A TW 94110887 A TW94110887 A TW 94110887A TW I351277 B TWI351277 B TW I351277B
- Authority
- TW
- Taiwan
- Prior art keywords
- reduced coenzyme
- composition
- coenzyme
- oil
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000005515 coenzyme Substances 0.000 claims description 62
- 235000013305 food Nutrition 0.000 claims description 15
- SOECUQMRSRVZQQ-UHFFFAOYSA-N ubiquinone-1 Chemical compound COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O SOECUQMRSRVZQQ-UHFFFAOYSA-N 0.000 claims description 14
- 238000007254 oxidation reaction Methods 0.000 claims description 13
- 230000003647 oxidation Effects 0.000 claims description 12
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 11
- 235000013793 astaxanthin Nutrition 0.000 claims description 11
- 239000001168 astaxanthin Substances 0.000 claims description 11
- 229940022405 astaxanthin Drugs 0.000 claims description 11
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 10
- 239000002537 cosmetic Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 230000008030 elimination Effects 0.000 claims description 7
- 238000003379 elimination reaction Methods 0.000 claims description 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 7
- 229940127557 pharmaceutical product Drugs 0.000 claims description 7
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 5
- 229940000033 dermatological agent Drugs 0.000 claims description 2
- 239000003241 dermatological agent Substances 0.000 claims description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims 1
- 229940097275 indigo Drugs 0.000 claims 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 49
- 235000021466 carotenoid Nutrition 0.000 abstract description 45
- 150000001747 carotenoids Chemical class 0.000 abstract description 44
- 230000000694 effects Effects 0.000 abstract description 20
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 17
- 239000001301 oxygen Substances 0.000 abstract description 17
- 229910052760 oxygen Inorganic materials 0.000 abstract description 17
- 239000003963 antioxidant agent Substances 0.000 description 40
- 235000006708 antioxidants Nutrition 0.000 description 40
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 238000011156 evaluation Methods 0.000 description 23
- -1 mycolipid Chemical compound 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 150000003254 radicals Chemical class 0.000 description 13
- 239000000052 vinegar Substances 0.000 description 11
- 235000021419 vinegar Nutrition 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 229940088594 vitamin Drugs 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 235000017471 coenzyme Q10 Nutrition 0.000 description 7
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 238000006722 reduction reaction Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 229940105990 diglycerin Drugs 0.000 description 5
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 5
- 235000012680 lutein Nutrition 0.000 description 5
- 229960005375 lutein Drugs 0.000 description 5
- 239000001656 lutein Substances 0.000 description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000000524 Thiobarbituric Acid Reactive Substance Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 150000004667 medium chain fatty acids Chemical class 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 3
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 239000004212 Cryptoxanthin Substances 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 3
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 3
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 3
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019244 cryptoxanthin Nutrition 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 235000010930 zeaxanthin Nutrition 0.000 description 3
- 239000001775 zeaxanthin Substances 0.000 description 3
- 229940043269 zeaxanthin Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PHDVPEOLXYBNJY-KTKRTIGZSA-N 2-(2-hydroxyethoxy)ethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCO PHDVPEOLXYBNJY-KTKRTIGZSA-N 0.000 description 2
- BHUPIKYIGMWGAD-UHFFFAOYSA-N 2-amino-9-(hydroxymethyl)-3-oxophenoxazine-1-carboxylic acid Chemical compound C1=CC=C2OC3=CC(=O)C(N)=C(C(O)=O)C3=NC2=C1CO BHUPIKYIGMWGAD-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000000530 Alcea rosea Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical class CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OGELJRHPEZALCC-UHFFFAOYSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(O)COCC(O)CO OGELJRHPEZALCC-UHFFFAOYSA-N 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- AFQPSLVGGMCBOR-XHGAXZNDSA-N alpha-Carotin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C AFQPSLVGGMCBOR-XHGAXZNDSA-N 0.000 description 1
- ANVAOWXLWRTKGA-JLTXGRSLSA-N alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-JLTXGRSLSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- 239000002663 humin Substances 0.000 description 1
- 229940079826 hydrogen sulfite Drugs 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000006492 vascular dysfunction Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Description
1351277 九、發明說明: 【發明所屬之技術領域】 本發明係一種含有還原型輔酶卩1()及類胡蘿蔔素類之抗 氧化力優異的組合物及使用該組合物而消除活性氧及/或 自由基之方法》還原型辅酶Q1〇及類胡蘿g素類在作為食 品、營養食品、特定保健用食品、營養輔助劑、營養劑、 動物藥、飲料、飼料、化妝品、醫藥品、治療藥、預防藥 等方面,是屬有用之化合物。 【先前技術】 輔酶Q是一種從細菌以至哺乳動物,廣泛在生物體内分布 之必要成分,其係以生物體内細胞中之粒線體的電子傳遞 系統構成成分為人所知。辅酶Q係藉由在粒線體内重複進行 氧化及還原而擔當電子傳遞系統中傳達成分之機能。就人 類而言,輔酶Q之侧鏈具有10個重複構造之輔酶Qig係其主 成分,在生物體内,係在氧化型輔酶Qig與還原型辅酶Qi〇 之比保持為一定下發揮機能,通常,據信有4〇〜9〇%左右係 以還原型存在。輔酶Q之生理作用,包含利用粒線體賦活作 用的胃b量產生之活化、心機能之活化、細胞臈之安定化效 果、源自抗氧化作用之細胞保護效果等等。 如上所述,輔酶Q1〇有氧化型及還原型之存在還原型辅 酶Qio因具有抗氧化作用之故,若對血中送入充分量之還原 型輔酶Q10’將可有效增加血中之抗氧化力。增加血中之抗 氧化力對於虛血再回流時之血管障礙、動脈再狹窄、腦 栓塞後血管障帛、動脈硬π、糖尿病合併症等會因活性氧 100513-1000513.doc -6 - 1351277 而心化之許多疾病的防止及預防十分有用。 ▲。方面,類胡蘿蔔素類係一種廣泛存在於自然界植物 > =或果實、蔬菜等,或是藻類中之色素。類胡蘿蔔素據 仏可保護生物不受在植物或藻類之細胞内行光合作用時所 產生之活性氧之影響。此外,在攝取此等植物之動物中亦 有廣泛的分布,在蟹或蝦之甲殼或鮭魚之肌肉中,在海膽、 ;丨黑鱈之卵等等之中亦有包含。已有類胡蘿蔔素類含量少 之卵的孵化率顯著低落之報告,雖然並不明確,就連動物 也會保護自身免受活性氧等之侵犯。 類胡蘿蔔素之種類有在蕃茄中多量含有之菌脂色素,在 大蒜中多量含有之P-胡蘿蔔素,此外,還包括α-胡蘿萄素、 蝦月素、隱黃素、玉米黃素、葉黃素、斑螯黃素、墨角藻 黃質、維生素Α等等,對於食用含此等成分之食物的人類, 據k類胡蘿蔔素具有非常重要的作用。 例如,β-胡蘿蔔素有抑制癌症發病的報告(M. M.
Mathews-Roth, Pure Appl. Chem·,57, 717-722,1984:非專利 文獻1) ’菌脂色素有抑制大腸癌的報告(T.Narisawa,et al;
Jpn. J. Cancer Res” 89,1003-1008,1998 :非專利文獻 2), 葉黃素或玉米黃素有降低加齡性網膜黃斑變性症之危險的 報告(J. M. Seddon,et al; JAMA,272,1413-1420,1994 :非 專利文獻3),蝦青素有改善眼睛之調節機能障礙 (WO02/094253 :專利文獻1)及預防-改善白内障之效果(特 開平10-276721號公報:專利文獻2) ^此等類胡蘿蔔素類係 在分子内具有異戊間二稀之四祐類,業界期待與其類似之
S 100513-1000513.doc 1351277 構造體能在生物體内發揮相同之作用。 上述效果中之許多效果,據传传扣 佩係起因於還原型辅酶Q10及 類胡蘿蔔素類所具有之抗氧化力,绰+ ^ L t 77琛5之’將在生物體内 發生之活性氧及/或自由基予以消除之效果。因之,還原型 輔酶Q1〇或上述類胡蘿葡素類在生物體内擔當非常重要的 任務’相信將其攝取入體内對生物有利。 然而,還原型輔酶Q1()對於空氣之氧化非常不安定,有不 易使用的一面。因此,本發明人等曾發明一種含還原型輔 酶Q1Q與各種抗氧化劑之可將還原型輔酶Q1()安定保持之製 劑(特開2003-1 19127:專利文獻3^但是,即使是此種安定 化之還原型輔酶Q1C,仍有發揮上述各種效果之抗氧化力不 充分,即活性氧及/或自由基消除效果不足之情形,提高上 述效果之方法及可提高該效果之製劑,是所企盼者。 另一方面,類胡蘿蔔素類亦同’被期待對於生物體可顯 示有用之效果,但其消除生物體内之活性氧及/或自由基之 效果並不充分,因此’在生物體内所能發揮之上述效果亦 " _ — - · - - - - - . 不充分令人滿意。 [專利文獻 l]WO02/094253 [專利文獻2]特開平10-276721號公報 [專利文獻3]特開2003-119127號公報 [非專利文獻 1]M. Mathews-Roth,Pure Appl. Chem·, 57, 717-722,1984 [非專利文獻 2] T.Narisawa, et al; Jpn. J. Canaer Res·,89, 1003-1008, 1998 I00513-1000513.doc 1351277 [非專利文獻 3]J. M. Seddon,et al; JAMA,272, My 1420, 1994 【發明内容】 本發明之目的係在提供一種還原型輔酶Qi〇或類胡蘿芍 素類所具有之活性氧及/或自由基消除作収能有效發: 之組合物,以及一種使用此等組合物而消除活性氧及/或自 由基之方法。 發明人等為解決上述課題,銳意研討之結果發現,在還 原型輔酶Q1()及類胡蘿g素類共存之情形下與各者單獨之 情形相較,活性氧及/或自由基消除作用相乘性地提高此— 值知注目之新知識,遂而完成本發明。 具體而言,本發明係有關一種活性氧及/或自由基消除作 用相乘性地提高之組合物’其特徵為含有還原型輔酶仏'。及 類胡蘿蔔素類。 本發明又㈣-種使用含有還原型輔酶^。及類胡蘿勢 素類之組合物而消除活性氧及/或自由基之方法。 根據本發明,可提供活性氧及/或自由基消除效果提高之 組合物。 【實施方式】 以下,兹將本發明詳細說明之。本發明之組合物,作為 其必要成分,含有還原型輔酶Qi〇及類胡蘿萄素類。藉由同 時含有還原型輔酶Qh及類㈣g素類,可形成抗氧化力, 即活性氧及/或自由基消除作用相乘性地提高之組合物。 此處,「活性氧及/或自由基消除作用相乘性地提高」,係 J00513-1000513.doc 1351277 指以實施例中所詳述之方法測定還原型輔酶Qi〇及類胡蘿 蔔素類共存時之抗氧化力之場合,其值係超過以同法測 定還原型輔酶Q10單獨之抗氧化力(B)及類胡蘿蔔素單獨之 抗氧化力(C)之和。具體而言,各抗氧化力之測定結果代入 下述評價式a : A/(B+ Oxioo 時,其值超過100, (評價式a) 宜為105以上,更好的是在110以上。 此外,還意味著還原型輔酶及類胡蘿蔔素類共存時之 還原型輔酶Q1()所具有之抗氧化力,較單獨使用還原型輔酶 Q1〇時之抗氧化力為高。具體而言,各抗氧化力之測定結果 代入下述評價式b : (A- C)/Bxl〇〇 (評價式 b) 時,其值超過100’宜為105以上,更好的是在11〇以上再 好的疋120以上’特別好的是丨3〇以上。 本發明中所使用之還原型輔酶例如可由合成、發酵、 自天然物萃取等之習用方法爸苎,更好的是」將既存高純 度辅酶Q1G等之氧化型辅酶Q1G、或氧化型輔酶Qi〇與還原型 輔酶Qlfl之混合物,以一般之還原劑,例如利用亞硫酸氫 鈉、氫硼化鈉、抗壞血酸等還原而獲得。 組合物中之還原型輔_Q10比例若過少時,無法獲得期待 之抗氧化力,因此,組合物中還原型辅酶Ql〇之比例通常為 0·01重量%以上,更好的是1重量%以上,再好的是1〇重量% 以上,特別宜在30重量%以上,其t更好的是6〇重量%以 上。上限雖未特別限制,但基於經濟觀點,通常為9〇重量 100513-1000513.doc •10- 1351277 %以下,宜為80重量%以下,更好的是7〇重量%以下。 本發明所用之還原型辅酶Q1〇可為單獨,也可為與氧化型 輔酶Q1〇之混合物,輔酶Ql。含量中,還原型輔酶Qi。之比例 0宜為60重量%以上,更好㈣重量%以上,再更好⑽重量 %以上’甚至以90重量%以上更好,最好的是95重量以上。 上限是100重量%,並未特別限定,普通為99 9重量%以下。 作為類胡蘿蔔素類,可舉的是蝦青素、p胡蘿蔔素、α_ 胡蘿蔔素、菌脂色素、隱黃素、玉米黃素、葉黃素、斑螯 黃素、墨角藻黃質、維生素Α等等。其中較好的是蝦青素、 P-胡蘿萄素、α-胡蘿葡素、菌脂色素、隱黃素、葉黃素、 維生素Α等等。再好的是蝦青素、ρ·胡蘿萄素、以·胡蘿蔔素、 菌脂色素、葉黃素、維生素Α等等。更好的是蝦青素、β· 胡蘿範素、菌脂色素、維生素Α等等,特別好的是瑕青素、 β_胡蘿蔔f、菌脂色素’最好的是蝦青素。此等類胡蘿蔔 素類可為化學合成者,也可為自天然物萃取或純化者。 有關含此等類胡蘿萄素類之天然物,包含藻類、酵母菌、 植物浮游生物、果實、蔬菜、香草、甲殼類、蛋類等等。 本發明之特徵係在使用含還原型輔酶Qi〇及類胡蘿蔔素 類之組合物,此時,相對還原型輔酶〇丨。之類胡蘿g素類的 重量比,通常為Ο.ίΗ以上,宜為Q G1以上,更好的是〇㈣ 上。上限雖未特別限制,但基於經濟觀點,通常為1〇以下, 宜為1以下,更好的是〇!以下。 又,本發明組合物中可含油脂。本發明所使用之油脂, 可為得自動植物之天然油脂,也可為合成油脂或加工油 100513-1000513.doc 1351277 脂。作為植物油脂,可舉的是揶子油、棕櫚油、棕網仁油、 亞麻仁油 '椿油、玄米庇芽油、菜軒油、米油、花生油、 玉米油、小麥胚芽;由、大豆油、莊麻油、棉籽油、向曰葵 種:’由、panha油、月見草油、乳油木果油、野扇花脂可 了脂、麻油、k花油 '撖欖油等。作為植物油脂,可舉的 是豬油、乳脂、魚油、牛油等等。此外可舉的是將此等天 油知作刀餾、加氫、酯交換、而加工成之油脂(例如硬化 油)。無庸置疑,中鏈脂肪酸甘油三酯(MCT)、脂肪酸之部 刀甘油S曰、丙一醇脂肪酸酯、璃脂質等亦可使用。 作為中鏈脂肪酸甘油三酯,可舉的是例如脂肪酸之碳數 为別為6〜12 ’宜為8〜12之甘油三酯。作為脂肪酸之部分甘 油Sa ’可舉的是例如脂肪酸之碳數分別為6〜18,宜為6〜12 之甘油早醋或甘油二g旨。 作為丙二醇脂肪酸酯,可舉的是例如脂肪酸之碳數分別 為6〜18 ’宜為6〜12之甘油單酯或甘油二酯。 作為填脂質,可舉的是例如蛋黃卵磷脂、純化大豆卵磷 脂、填脂醯膽鹼、磷脂醯乙醇胺、磷脂醯絲胺酸、勒磷脂、 一錄蝶基碟酸、硬脂胺、磷脂醯甘油、磷脂酸、磷脂醯肌 醇胺、心麟脂、神經醯胺碟酸乙醇胺、神經醯胺鱗酸甘油 以及此等之混合物等等。 上述油脂中,基於處理容易性、臭氣等層面之考量’較 佳的是植物油脂、合成油脂或加工油脂、磷脂質,其宜在 考慮油脂之價格、還原型輔酶Q丨〇及類胡蘿g素類之安定性 等下選定。例如較佳的是椰子油、棕櫚油、棕櫊仁油、菜 100513-1000513.doc •12· 1351277 ㈣、米油、大豆油、棉軒油、撤搜油、红花油、MCT、 磷脂質等,待別好的是米油、大豆油、菜軒油红花油、 MCT、磷脂質等。 相對此等油脂之還原型辅酶Qi〇的重量比,通常為〇1%以 上’宜為1%以上’更好的是1〇%以上。上限雖未特別限制, 通常為90%以下,宜為8〇%以下,更好的是7〇%以下。 本發明組合物中,除了還原型 ^ , -Γ ^ ^ ^ 補酶Qio及類胡蘿蔔素類 2广添加其他素材。作為素材並無特殊限制例 “可舉的疋R形劑、崩壞劑、潤滑劑、結合劑、抗氧化劑、 者色劑、凝集防止劑、吸從促進劑、有效成分之溶解輔助 劑、安定化劑等等。 解輔助 作為上述賦形劑,並無特殊限制, 乳糖、葡萄糖、玉f澱p ^ 牛.疋列如白糖、 J句裙王,卡殿粉、甘露糖醇、結 鈣、硫酸鈣等等。 ’’、素、y酸 作為上述崩壞劑,並無特殊限制,可兴 瓊脂、檸檬酸鈣、碳酸鈣、碳酸氫鈉、糊精、殿粉、 羧甲基纖維素、黃蓍膠等。 曰曰纖維素、 作為上述潤滑劑,並無特殊限制, 硬脂酸鎂、聚r·•醢访τ 举的疋例如滑石、 鎂“-醇、矽石、硬化植物油等。 作為上述結合劑,並無特殊限制,可舉 维素、f基纖维素、㈣基甲基纖維素、^例如乙基纖 明膠、阿拉伯樹膠、聚乙稀基…綱“膠、蟲夥、 烯酸、聚甲基丙烯酸、山梨糖醇等。 烯醇、聚丙 作為上述抗氧化劑,並無特殊限制 舉的是例如抗壞 100513-1000513.doc
S •13. 1351277 酸生月紛亞硫酸氫麵、硫代硫酸納、焦亞硫酸納、 檸檬酸等。 作為上述著色劑,並無特殊限制,可舉的是例如可添加 於醫藥品、食品中者。 作為上述凝集防止劑,並無特殊限制,可舉的是例如硬 脂酸、滑石、輕質矽酸酐、含水二氧化矽酸等。 作為上述吸收促進劑,並無特殊限制,可舉的是例如高 級醇類、高級脂肪酸類、蔗糖脂肪酸酯或山梨糖醇酐脂肪 酸醋、聚氧化乙烯山梨糖醇軒脂肪酸醋、聚甘油脂肪酸醋 等之界面活性劑等等,基於還原型輔酶Qi。或類胡蘿萄素類 之安定性等之觀點,特別好的是聚甘油脂肪酸醋。其中, 就HLB而言,其下限通常為4以上,更好的是5以上再好 的是6以上,又更好的是7以上,尤好的是8以上;其上限通 常為12以下,更好的是n以下,再好的是1〇以下。 聚甘油脂肪酸酯之較佳具體例為二甘油癸酸酯、二甘油 一月桂酸醋、四甘油一月桂酸醋、二甘油一油酸醋、二甘 ,二油酸醋、四甘油一油酸醋、十甘油五油酸醋,較佳的 是二甘油一月桂酸酯、二甘油一油酸酯,最好的是二甘油 一油酸酯。 / 作為上述有效成分之溶解辅助劑,並無特殊限制’可舉 的是例如富馬酸、琥珀酸、蘋果酸等之有機酸。 作為上述安定化劑,並無特殊限制,可舉的是例如笨 酸、苯甲酸鈉、對氧苯甲酸乙酯等。 又,本發明組合物中,可含還原型輔酶Qi〇及類胡蘿蔔素 100513-1000513.doc -14· 135.1277 類以外之活性成分。 基酸、維生素、礦物 質等。 作為此種活性成分, 質、多酚、有機酸、 可舉的是例如胺 糖類、肽、蛋白 酸= 添加吸收促進劑,特別是添加聚甘油腊肪 二’可大幅增加還原型輔酶Qi。及類胡㈣素 吸收性,可有效發揮本發明組合物所具有之抗氧化性。 含還原型辅酶Q10及類胡蘿霉素類之組合物可原狀使
用,也可進而加工成谬囊劑(硬膠囊、軟膠囊、微廢囊)、鍵 劑、糖漿劑、飲料等經口投與形態,作為經口劑使用。此 外,也可進而加工成牙膏等形態使用。特別好的是朦囊劑, 尤其是軟夥囊。 作為膠囊基材,並無特殊限制,可使用以得自牛骨、牛 皮、豬皮、魚皮之明膠為首之基材,或其他基材,例如可 使用作為食品添加物供使用之角又膠、藻酸等之海藻由來 物、或刺槐豆膠或癒創木膠等之植物種子由來物、支鏈澱
粉、卡德藍糖等之為生物由來物、或含纖維素類之製造用 劑0 又’本發明含還原型輔酶Q10及類胡蘿蔔素類之組合物, 可添加至一般之食品中。例如,可適當添加至麵包、義大 利麵、鹹稀飯、米飯、餅乾、小西點、蛋糕、日本小餅乾、 口香糖、糖等中使用。無疑’也可以其他之食品形態利用。 再者’本發明含之組合物,可以直接塗布於皮膚之形態, 作為皮膚用劑使用❶此時,其劑型並無特殊限制,例如, 可為在適當基劑中溶解或混合分散上述組合物,而形成為 100513.1000513.doi 15 1351277 乳霜狀、糊狀、果凍狀、凝膠狀、乳液狀、液狀之形狀而 獲得者(軟膏劑、塗敷劑、乳劑、喷劑等),將在基劑中溶解 或混合分散上述藥物所得之物在支持體上展延成之物(濕 '占片丨等)’將在钻者劑中溶解或混合分散上述組合物所得之 物在支持體上展延成之物(塑性劑、貼帶劑等)。 本發明之組合物,及以該組合物為有效成分之經口劑或 皮膚用劑,具有相乘性提高之活性氧及/或自由基消除作 用,有用於保護生物體免受起因於活性氧及/或自由基之障 礙。 又,由於還原型輔酶Ql〇及類胡蘿蔔素類共存所發揮之相 ,|生提网之活性氧及/或自由基消除作用,亦有用於食品、 醫藥製品或化妝品之抗氧化。亦即,藉由使還原型辅酶q丨。 及類胡蘿蔔素類同時含於食品、醫藥製品或化妝品中,可 有效抑制食品、醫藥製品或化妝品之氧化。 由本方法抑制氧化之食品、醫藥製品或化妝品
I _ - _<»*> "7’J 限制’在含有易於氧化之油脂之食品、醫藥製品或化妝 品之場合特別有效。 - 在食品、醫藥製品或化妝品中同時含有還原型辅酶〜及 類胡蘿®素類之方法並無特殊限制,可在此等製品製造過 =中添加還原型輔酶—及類胡㈣素類,或在製成之食品 1添加另行調製之含還原型輔酶Q滅類胡蘿蔔素類之組 合物。 但本發明不受此 以下,茲舉實施例將本發明詳細說明 等實施利之限制。 100513-1000513.doc [抗氧化力之測定法] (測定法1) 本方法首先係使用測定由氧化反應所產生之硫巴比土酸 反應性物質(TBARS)的量之手法(8116§6 1.八.311£1八1^8· D·; Methods Enzynol·,1978, 52,302)。 本方法首先係將大鼠之腦在2.5倍重量之生理食鹽水中 均質化,獲得腦均質液。在此腦均質液80 μΐ中,作為試料 添加含抗氧化物質之乙醇溶液30 μΐ、eagle MEM培養基120 μ 卜 CuSO4(240 μΜ)及 FeCl3(240 μΜ),保持於37。。。27 小時 後,添加20% TCA溶液0.9 ml及0.67%硫帶巴比妥酸溶液0.9 m卜在100°C下加熱30分鐘。在水冷及離心分離後,分取上 清液,測定532 nm之吸光度。在本測定中,抗氧化物質之 抗氧化愈強則TBARS之量愈少,將相對未添加抗氧化物質 時之TB ARS量,添加抗氧化物質時減少之TB ARS量的比 例,設為該抗氧化物質之抗氧化力(%)。 (測定法2) TBARS因係紅色物質,依組合物之種類,根據上述測定 法1,有無法測定正確吸光度之情形。是以,另使用用到 DPPH(1,1-二苯基-2-苦基環次聯胺基)之分光測定法(篠原 和毅鈴木建夫;食品機能研究法,2000, 218)。 本測定法2中,首先係在400 μιη之DPPH乙醇溶液12 ml 中,加200 mM之MES緩衝液(ρΗ6·0) 12 ml,再添加12 ml之 乙醇,調製成混合液。在此混合液0.9 ml中,添加含抗氧化 物質之乙醇溶液0.6 m卜20分鐘後,測定510 nm下之吸光 100513-1000513.doc -17- 1351277 度。在本測定系中’抗氧化物質之抗氧化愈強則吸光度愈 小’從使用兒茶酸製成之檢量線,定量各抗氧化物質之抗 氧化力°亦即’首先以充分量之兒茶酸消除DPPH自由基, 設最低值吸光度顯示之場合的抗氧化力為1〇〇%,設未添加 兒条酸時’即DPPH全量殘存時之吸光度時之抗氧化力為 0 /〇。而後,使用此2點作成之檢量線,自添加各抗氧化物 質時之吸光度,求得抗氧化力(%)。 [評價式] 依上述測疋法測定還原型辅酶Qio及類胡蘿g素類併用 時之抗氧化力(A) ’還原型輔酶qi〇單獨之抗氧化力(B)及類 胡蘿蔔素單獨之抗氧化力(C)。將併用時之抗氧化力,與還 原型辅酶Q10單獨之抗氧化力及類胡蘿蔔素單獨之抗氧化 力的和比較,判定併用是否有相乘效果。 本發明中還原型輔酶Qi〇及類胡蘿g素類併用時是否有 相乘效果,為求正確,係以下述兩種方法評價。 (評價式 a) A/(B + C)xl〇〇 (評價式 b) (A—C)/Bxl〇〇 式中,A表示還原型輔酶Qi〇及類胡蘿萄素類併用時之抗 氧化力,B表示還原型辅_。單獨之抗氧化力,C表示類胡 蘿蔔素單獨之抗氧化力。 評價式a係將還原型辅叫。及類㈣蔔素類併用時之抗 氧化力與個別單獨抗氧化力之和比較。在有相加效果時, 理論值為100,若為超過100之結果。判斷有相乘效果。 另外’評價式b係將還原型輔酶Q10及類胡蘿葡素類併用 I005I3-I0005I3.doc 135.1277 時之還原型辅酶(^〇的抗氧化力與還原型輔酶Q1q單獨的抗 氧化力比較。在式中’自併用還原型輔酶Q10及類胡蘿蔔素 類之抗氧化力減去類胡蘿萄素單獨之抗氧化力,在只有相 加效果時’此值會與還原型輔酶Q1〇單獨之抗氧化力相等。 因此’式之理論值為100,若為超過1〇〇之結果。判斷有相 乘效果。 (參考例) 在1000 g乙醇中,添加100g氧化型辅酶Qi(^6〇g2L抗 壞血酸,在78°C下攪拌,進行還原反應。3〇小時後,冷卻 至5 0°C ’在保持同溫下’加入乙醇4〇〇 g及水1〇〇 g。將此乙 醇溶液在攪拌下以1 〇°C /小時之冷卻速度冷卻至2它,濾出 生成之結晶。將獲得之濕結晶依冷乙醇、冷水之順序洗淨 後,予以減壓乾燥,獲得白色之乾燥結晶95 g(有形收率% 莫耳%)。又,除減壓乾燥外之所有操作’係在氮氣環境下 貫施。所獲得之結晶的還原型輔酶Qig/氧化型輔酶Qm之重 量比為99.5/0.5。 (實施例1) 將參考例1所得之還原型輔酶Qi(>及/或類胡蘿菌素類之一 之瑕月素之乙醇溶液(分別為1〇〇 mM)作為試料,以上述測 疋法1,測定其抗氧化力。將各測定結果代入上述(評價式 a)及(評價式b),判定有無相乘效果。如表〖所示,評價式a 為135,5平價式b為2〇5,確認還原型辅酶及類胡蘿蔔素 類共存時抗氧化力明顯增加。 1〇〇513· lGGG513.doc -19- 1351277 【表1】 抗氧化力(%) (氧化之抑制率) 評價式a 評價式b A/(B + C)x100 (A-C)/ BxlOO 還原型輔酶Q1〇 10.9 — —— 蝦青素 21.6 — — 還原型輔酶Q1〇及 蝦青素 43.9 135 205 A:合併使用還原型輔酶Q10及類胡蘿蔔素類時之抗氧化力 B:還原型輔酶Q1〇單獨之抗氧化力 C:蝦青素單獨之抗氧化力 (實施例2) 將參考例1所得之還原型辅酶q1g及/或卜胡蘿萄素、還原 型辅酶及/或菌脂色素之乙酵溶液(分別為25 μΜ)作為該 料,以上述測定法2,測定其抗氧化力。將各測定結果代入 上述(評價式a)及(評價式b),判定有無相乘效果。如表2所 示’還原型輔酶Q丨。與β-胡蘿S5素時,評價式&為1〇7,評價 式b為114 ;還原型輔酶q1〇與菌脂色素時,評價式&為, 評價式b為105。由以上可知,還原型輔 ··‘、* 素,或還原龍酶Ql。與菌脂色素共存時,確認=-胡蘿萄 顯有相乘效果。 u几氧化力明 100513-10005l3.doc •20-
20.5 0. 9 11.7 107 114 105 還原型辅酶Q1() 石-胡蘿蔔素 還原型輔酶Q1〇與 石-胡蘿蔔素 菌月旨色素 還原型輔酶Q1〇與 素 A:合併使用還原型輔酶 力 l還原型輔酶Ql0單獨之抗氧化力萄素時之抗氧化 C · β_胡蘿蔔素或菌脂色素單獨之抗氧化力 (比較例1) 2用參考m所得之還原型辅酶Q1Q及維生素£,依完全同 例1之方式進行研討。其結果為,評價式&為90,評 =為80,在還原型輔酶仏❶及維生素ε之場合,並未 乘效果。 (貫施例3) 在米/由' 硬化油、蜜蠟、卵磷脂、二甘油一油酸酯之混 〇物中’添加參考例1所得之還原型輔酶Q1()及蝦青素,依 吊法獲得下述成分所構成之明膠的軟膠囊製劑。 還原型輔酶Qio 60重量份 瑕青素 10重量份
100513-1000513.doc -21 - S 1351277 米油 5 00重量份 二甘油一油酸醋 i 180重量份 硬化油 170重量份 蜜蠟 60重量份 卵磷脂 20重量份 (實施例4) 在中鏈脂肪酸甘油三酯(MCT,碳數8:碳數10=6: 4)中, 添加參考例1所得之還原型輔酶Ql()及維生素£,依常法獲得 下述成分所構成之明膠的軟膠囊製劑。 還原型輔酶Q1q 60重量份 維生素E 5重量份 中鏈脂肪酸甘油三酯 93 5重量份 (實施例5) 將參考例1所得之還原型輔酶Q10及菌脂色素(蕃茄萃取 物)溶解於丙醇中, 將其吸附於微結晶纖維素後,在減壓下 乾燥。於氮氣環境下,混合以玉米殿粉、乳糖、羧曱基纖 維素、硬脂酸鎂, 再加入作為結合劑之聚乙烯基吡咯咬綱 之水溶液,依常法與以顆粒化。之後,在其中添加滑石作 為濁滑劑混合後, 予以打錠成键劑·。 還原型辅酶Q1() 150重量份 菌脂色素 10重量份 玉米澱粉 200重量份 乳糖 120重量份 羧曱基纖維素 80重量份 100513-1000513.doc -22- 1351277 微結晶纖維素 300重量份 聚乙烯基吡咯啶酮 40重量份 硬脂酸鎂 20重量份 滑石 80重量份 (實施例6) 依常法調製含參考例1所得還原型輔酶Qio及蝦青素之下 述組成之乳霜。
還原型輔酶Q10 10重量份 瑕青素 1重量份 甘油山梨糖醇酐脂肪酸酯 60重量份 微結晶性蠟 10重量份 撖欖油 30重量份 流動石蠟 180重量份 硬脂酸鎂 10重量份 丙二醇 37重量份 硫酸鎮 7重量份 脫鹽水 655重量份 100513-1000513.doc -23-
Claims (1)
1351277
2. 3. 4. 5. 6. 8. 9. 申請專利範圍: 一種可使活性氧及/或自由基消除作用相乘性地提高之组 合物’其係含有還原型輔酶Q1〇及瑕青素,且相對於還原 型輔酶Q1G之蝦青素的重量比為0 01以上。 如請求们之組合物,其中相對於還原型辅酶之瑕青素 的重量比為0.01〜10。 如請求項1之組合物,其係進而含有油脂。 如請求項3之組合物’其中相對於油脂重量之還原型辅酶 Ql 0的重量比為0. 1 %以上。 如請求们〜钟任—項之組合物,其係被加工成經 形態。 如請求項1〜4中任-項之組合物,其具有供直接塗布於皮 膚之形態。 -種經口投與劑,其係以請求項卜4中任一項之組合物作 為有效成分。 種皮膚用劑’其係以請求項卜4中任_項之組合物作為 有效成分。 … -種=品、醫藥製品或化妝品之氧化防止方法,其特徵 月求項1〜4中任一項之組合物添加至食品、醫藥製品 或化妝品中。 ' "β 100513-1000513.doc S
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004116054 | 2004-04-09 | ||
JP2004262975 | 2004-09-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200603785A TW200603785A (en) | 2006-02-01 |
TWI351277B true TWI351277B (en) | 2011-11-01 |
Family
ID=35124815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094110887A TWI351277B (en) | 2004-04-09 | 2005-04-06 | Compositions containing reduced coenzyme q10 and c |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1733720B1 (zh) |
JP (2) | JP5243718B2 (zh) |
AT (1) | ATE555674T1 (zh) |
TW (1) | TWI351277B (zh) |
WO (1) | WO2005097091A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9655966B2 (en) * | 2002-08-28 | 2017-05-23 | Kedar N. Prasad | Micronutrient formulations for radiation applications |
ATE555674T1 (de) * | 2004-04-09 | 2012-05-15 | Kaneka Corp | Zusammensetzung mit der reduzierten form von coenzym q10 und carotenoid-verbindung |
KR101323904B1 (ko) * | 2005-07-15 | 2013-10-30 | 디에스엠 아이피 어셋츠 비.브이. | 유기 화합물의 신규 용도 |
US20070078180A1 (en) * | 2005-10-04 | 2007-04-05 | Kern Dale G | Methods and compositions for stabilizing an antioxidant |
WO2008035757A1 (fr) * | 2006-09-22 | 2008-03-27 | Kaneka Corporation | Aliment de type gelée contenant de l'ubiquinol |
JP4868587B2 (ja) * | 2006-09-26 | 2012-02-01 | ユニチカ株式会社 | クリプトキサンチン含有組成物 |
JP4717790B2 (ja) * | 2006-12-04 | 2011-07-06 | 理研ビタミン株式会社 | カロテノイド製剤 |
US8815567B2 (en) | 2007-11-30 | 2014-08-26 | E I Du Pont De Nemours And Company | Coenzyme Q10 production in a recombinant oleaginous yeast |
JP5674262B2 (ja) * | 2008-08-08 | 2015-02-25 | 花王株式会社 | 染毛剤組成物 |
JP6170231B1 (ja) * | 2016-12-22 | 2017-07-26 | 株式会社タイショーテクノス | 色素製剤及びその製造方法、並びに加工製品及びその製造方法 |
DE102019218241A1 (de) * | 2019-11-26 | 2021-05-27 | Beiersdorf Ag | Wirkstoffkombinationen aus Ubichinol und Carrageenan und kosmetische oder dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2619491B2 (ja) * | 1988-08-11 | 1997-06-11 | サントリー株式会社 | アスタキサンチン含有組成物 |
CH680072A5 (zh) * | 1989-10-27 | 1992-06-15 | Nestle Sa | |
JPH0799932A (ja) * | 1993-09-30 | 1995-04-18 | Nippon Suisan Kaisha Ltd | ファフィア色素油を含有する健康食品 |
JPH09143063A (ja) * | 1995-11-22 | 1997-06-03 | Kose Corp | 外用に適する組成物 |
US8753675B1 (en) * | 2000-01-20 | 2014-06-17 | Raj K. Chopra | Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications |
JP2001199868A (ja) * | 2000-01-24 | 2001-07-24 | Moltobene:Kk | 外用剤 |
US20050070610A1 (en) * | 2000-05-09 | 2005-03-31 | Kenji Fujii | Dermal compositions containing coenzyme q as the active ingredient |
JP3928153B2 (ja) * | 2001-01-19 | 2007-06-13 | コスメディ製薬株式会社 | シート状貼付剤 |
JP3742602B2 (ja) * | 2001-05-09 | 2006-02-08 | 株式会社カネカ | 還元型補酵素qの安定な溶液 |
JP3822479B2 (ja) * | 2001-10-10 | 2006-09-20 | 株式会社カネカ | 還元型補酵素q水溶液の安定化組成 |
JP2003119127A (ja) * | 2001-10-10 | 2003-04-23 | Kanegafuchi Chem Ind Co Ltd | 安定な還元型補酵素q製剤 |
TWI329513B (en) * | 2001-10-12 | 2010-09-01 | Kaneka Corp | Use of reduced coenzyme q for lessening oxidative stress |
TW200302055A (en) * | 2002-01-18 | 2003-08-01 | Kaneka Corp | Ubiquinol-enriched fat-containing foods |
JP2003335668A (ja) * | 2002-05-21 | 2003-11-25 | Fuji Chem Ind Co Ltd | 経口用美肌用剤 |
JP3406911B1 (ja) * | 2002-08-28 | 2003-05-19 | アサヒ飲料株式会社 | コエンザイムq10を含む飲料及びその製造方法 |
US7169385B2 (en) * | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
ATE555674T1 (de) * | 2004-04-09 | 2012-05-15 | Kaneka Corp | Zusammensetzung mit der reduzierten form von coenzym q10 und carotenoid-verbindung |
-
2005
- 2005-04-04 AT AT05728842T patent/ATE555674T1/de active
- 2005-04-04 WO PCT/JP2005/006592 patent/WO2005097091A1/ja not_active Application Discontinuation
- 2005-04-04 EP EP05728842A patent/EP1733720B1/en active Active
- 2005-04-04 JP JP2006512065A patent/JP5243718B2/ja active Active
- 2005-04-06 TW TW094110887A patent/TWI351277B/zh active
-
2013
- 2013-01-25 JP JP2013012211A patent/JP2013079287A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW200603785A (en) | 2006-02-01 |
JP2013079287A (ja) | 2013-05-02 |
WO2005097091A1 (ja) | 2005-10-20 |
EP1733720A1 (en) | 2006-12-20 |
JPWO2005097091A1 (ja) | 2008-02-28 |
JP5243718B2 (ja) | 2013-07-24 |
EP1733720A4 (en) | 2009-05-06 |
ATE555674T1 (de) | 2012-05-15 |
EP1733720B1 (en) | 2012-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Becerra et al. | Lutein as a functional food ingredient: Stability and bioavailability | |
Kaur et al. | Functional and nutraceutical properties of pumpkin–a review | |
JP2013079287A (ja) | 還元型補酵素q10およびカロチノイド類を含有した組成物 | |
Bogacz-Radomska et al. | Commercialization aspects of carotenoids | |
Rodriguez-Amaya | Carotenes and xanthophylls as antioxidants | |
JP2011032171A (ja) | 美白用組成物 | |
JP2008179632A (ja) | 抗酸化剤 | |
US20110144200A1 (en) | Combination of carotenoids and epi-lutein | |
WO2012147842A1 (ja) | 美肌促進剤及びその利用 | |
US20050226858A1 (en) | Compositions containing reduced coenzyme Q10 and carotenoid | |
JP4358957B2 (ja) | フリーラジカル又は活性酸素を消去もしくは低減する剤 | |
JP2009062330A (ja) | 粉末組成物 | |
JP2014019660A (ja) | 活性酸素抑制剤 | |
JPWO2009048120A1 (ja) | アスタキサンチン含有水溶性組成物 | |
JP2009159929A (ja) | 油性組成物 | |
JP6005339B2 (ja) | 抗酸化活性を有する組成物並びにこれを配合した飲食品及び化粧品 | |
US20120004297A1 (en) | Agent for alleviating vascular failure | |
JP2015231975A (ja) | 微細藻類から抽出されたフコキサンチン | |
JP7201646B2 (ja) | 経口組成物 | |
JP2012072132A (ja) | 寿命延長剤 | |
JP2008110942A (ja) | アスタキサンチン、亜鉛及びセレンを含む抗酸化組成物 | |
JP2012246244A (ja) | 毛細血管退行抑制剤 | |
JPWO2012157290A1 (ja) | 非アルコール性脂肪性肝炎の予防改善剤 | |
JP2006069969A (ja) | 活性酸素除去機能を有する生体機能調整剤およびそれを含有する化粧用組成物及飲食品用組成物 | |
JP2006070114A (ja) | カロテノイド類含有抽出物の製法 |